Literature DB >> 31573883

The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy.

Parisa Naeli1, Fatemeh Yousefi1, Younes Ghasemi2,3,4, Amir Savardashtaki2,3, Hamed Mirzaei5.   

Abstract

Lung cancer is the first cause of cancer death in the world due to its high prevalence, aggressiveness, late diagnosis, lack of effective treatment and poor prognosis. It also shows high rate of recurrence, metastasis and drug resistance. All these problems highlight the urgent needs for developing new strategies using noninvasive biomarkers for early detection, metastasis and recurrence of disease. MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression post-transcriptionally. These molecules found to be abnormally expressed in increasing number of human disease conditions including cancer. miRNAs could be detected in body fluids such as blood, serum, urine and sputum, which leads us towards the idea of using them as non-invasive biomarker for cancer detection and monitoring cancer treatment and recurrence. miRNAs are found to be deregulated in lung cancer initiation and progression and could regulate lung cancer cell proliferation and invasion. In this review, we summarized recent progress and discoveries in microRNAs regulatory role in lung cancer initiation and progression. In addition, the role of microRNAs in EGFR signaling pathway regulation is discussed briefly. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Lung cancer; biomarker; biomarkers; cell death; diagnosis; microRNA; therapy.

Mesh:

Substances:

Year:  2020        PMID: 31573883     DOI: 10.2174/1566524019666191001113511

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  9 in total

Review 1.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

2.  Effects and mechanism of microRNA‑218 against lung cancer.

Authors:  Yan Chen; Ji-Lin Yang; Zhen-Zhen Xue; Qiu-Chen Cai; Chun Hou; Hong-Juan Li; Liu-Xin Zhao; Yin Zhang; Cheng-Wei Gao; Li Cong; Tian-Zuo Wang; Dong-Mei Chen; Guo-Sheng Li; Shi-Qing Luo; Qian Yao; Chan-Juan Yang; Qi-Shun Zhu; Chuan-Hai Cao
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

Review 3.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

4.  Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses.

Authors:  An-Gui Liu; Yu-Yan Pang; Gang Chen; Hua-Yu Wu; Rong-Quan He; Yi-Wu Dang; Zhi-Guang Huang; Rui Zhang; Jie Ma; Li-Hua Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm.

Authors:  Wei Wang; Zaoxiu Hu; Mingsheng Ma; Haoyuan Yin; Yunchao Huang; Guangqiang Zhao; Xin Cui; Qinling Sun; Yantao Yang; Yichen Yang; Biying Wang; Lianhua Ye
Journal:  Ther Clin Risk Manag       Date:  2021-12-03       Impact factor: 2.755

6.  Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients.

Authors:  Neda K Dezfuli; Shamila D Alipoor; Neda Dalil Roofchayee; Sharareh Seyfi; Babak Salimi; Ian M Adcock; Esmaeil Mortaz
Journal:  Front Oncol       Date:  2021-11-01       Impact factor: 6.244

7.  miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 5.

Authors:  Gai Zhang; Haijian Zheng; Ling Wang
Journal:  Oncol Rep       Date:  2022-07-22       Impact factor: 4.136

8.  MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.

Authors:  Veronika Petkova; Dora Marinova; Silva Kyurkchiyan; Gergana Stancheva; Evgeni Mekov; Darina Kachakova-Yordanova; Yanina Slavova; Dimitar Kostadinov; Vanyo Mitev; Radka Kaneva
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

9.  miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro.

Authors:  Xueqiang Wei; Yujie Lei; Minjie Li; Guangqiang Zhao; Yongchun Zhou; Lianhua Ye; Yunchao Huang
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.